Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Working Capital Changes: 2015-2020

Historic Other Working Capital Changes for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to $986,834.

  • Outlook Therapeutics' Other Working Capital Changes rose 109.03% to $986,834 in Q3 2020 from the same period last year, while for Sep 2020 it was $310,270, marking a year-over-year increase of 103.81%. This contributed to the annual value of $4.9 million for FY2024, which is 287.29% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Other Working Capital Changes of $986,834 as of Q3 2020, which was up 320.79% from -$446,948 recorded in Q2 2020.
  • In the past 5 years, Outlook Therapeutics' Other Working Capital Changes registered a high of $4.5 million during Q2 2019, and its lowest value of -$10.9 million during Q3 2019.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$641,140 (2019), whereas its average is -$1.1 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 12,906.41% in 2016, then spiked by 703.02% in 2019.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Other Working Capital Changes stood at -$2.2 million in 2016, then surged by 135.54% to $792,757 in 2017, then crashed by 232.78% to -$1.1 million in 2018, then surged by 72.55% to -$288,930 in 2019, then surged by 109.03% to $986,834 in 2020.
  • Its last three reported values are $986,834 in Q3 2020, -$446,948 for Q2 2020, and $59,314 during Q1 2020.